Stephen David Prior, Chief Strategy Officer at AN2 Therapeutics, Inc. (ANTX), sold 2,029 shares at $1.34 ($3K) on 2025-01-03, disclosed to the SEC on 2025-01-07.
Open-market sale of $3k ANTX by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |